Monday, June 4, 2012

Johnson & Johnson Prostate Cancer Drug Impresses

A new study shows that Johnson & Johnson‘s prostate cancer pill Zytiga dramatically slows the progression of the disease in men who are not yet sick enough to start chemotherapy. More...